Ethylene Oxide Neurotoxicity:A Cluster of 12 Nurses with Peripheral and Central Nervous System Toxicity
Neurol 46:992-998, Brashear,A.,et al, 1996
Clinicopath Conf
Hypertension, MI, and Cerebral Infarctions with Pheochromocytoma, Am J Med 100:357-36496., , 1996
Motor Neuron Disease:A Paraneoplastic Process Associated with Anti-Hu Antibody and Small-Cell Lung Carcinoma
Ann Neurol 40:112-116, Verma,A.,et al, 1996
Motor Neuron Disease with Parkinsonism
Arch Neurol 53:987-991, Qureshi,A.I.,et al, 1996
Unusual Clinical Presentations of Cortical-Basal Ganglionic Degeneration
Ann Neurol 40:893-900, Bergeron,C.,et al, 1996
Linomide Reduces the Rate of Active Lesions in Relapsing-Remitting Multiple Sclerosis
Neurol 47:895-900, Anderson,O.,et al, 1996
Clozapine-Induced Myotoxicity in Patients with Chronic Psychotic Disorders
Neurol 47:1518-1523, Scelsa,S.N.,et al, 1996
Increased Writing Activity in Neurological Conditions:A Review and Clinical Study
JNNP 61:510-514, vanVugt,P.,et al, 1996
Total Alopecia, Diabetes Mellitus, and Falls
Lancet 348:1420, Mueller-Schoop,J.W., 1996
Classification of Daily and Near-Daily Headaches:Field Trial of Revised IHS Criteria
Neurol 47:871-875, Silberstein,S.D.,et al, 1996
Neutralizing Antibodies During Treatment of Multiple Sclerosis with Interferon Beta-1b
IFNB MS Study Group & UBC MS. MRI Analysis Group, Neurol 47:889-8946., , 1996
Guidelines for Physicians with Patients on IFNB-1b:The Use of an Assay for Neutralizing Antibodies (NAB)
Neurol 47:865-866, Paty,D.,et al, 1996
Interferon Beta in Multiple Sclerosis
BMJ 313:1159, 1157, 1195996., Richards,R.G., 1996
Childhood Leukemia:Central Nervous System Abnormalities During and After Treatment
AJNR 17:295-310, Chen,C-Y.,et al, 1996
Exacerbation of Myasthenia Gravis Associated with Cocaine Use
Neurol 46:271-272, Daras,M.,et al, 1996
Acute Rectus Muscle Palsy in Children as a Result of Orbital Myositis
J Pediatr 128:230-233, Pollard,F.,et al, 1996
Prevalence of Parkinsonian Signs and Associated Mortality in a Community Population of Older People
NEJM 334:71-76, Bennett,D.A.,et al, 1996
Evolution of High-Intensity Basal Ganglia Lesions on T1-Weighted MR in Neurofibramotisis Type 1
AJNR 17:755-760, Terada,H.A.,et al, 1996
Risk of Stroke During Long-Term Anticoagulant Therapy in Patients After Myocardial Infarction
Ann Neurol 39:301-307, 2811996., Azar,A.J.,et al, 1996
Palliative Care in Neurology
Neurol 46:870-872, 5981996., Bernat,J.L.,et al, 1996
Restless Legs Syndrome and Leg Cramps in Fibromyalgia Syndrome:A Controlled Study
BMJ 312:1339, Yunus,M.B.&Aldag,J.C., 1996
Campylobacter Jejuni Infection and Anti-GM1 Antibodies in Guillain-Barre Syndrome
Ann Neurol 40:181-187, Jacobs,B.C.,et al, 1996
Antiamphiphysin Antibodies with Small-Cell Lung Carcinoma and Paraneoplastic Encephalomyel; itis
Ann Neurol 39:659-667, Dropcho,E.J., 1996
Another Kind of Knapsack Palsy
Neurol 46:585-586, Pringle,C.E.,et al, 1996
A 64-Year-Old Man with Diabetes and Ascending Paraplegia
Lancet 347:516, Gliemroth,J.,et al, 1996
Autonomic Ganglionitis with Severe Hypertension, Migraine, and Episodic but Fatal Hypotension
Neurol 47:817-821, Lee,H.C.,et al, 1996
Infarction of Superior Cerebellar Artery Presenting as Cerebellar Symptoms
Stroke 27:1679-1681, Terao,S.,et al, 1996
Clinical Heterogeneity of Adhalin Deficiency
Ann Neurol 39:196-202, Morandi,L.,et al, 1996
Diagnosis of Merosin (Laminin-2) Deficient Congenital Muscular Dystrophy by Skin Biopsy
Lancet 347:582-584, Sewry,C.A.,et al, 1996
Antiepileptic Drugs
NEJM 334:168-175, Brodie,M.J.&Dichter,M.A., 1996
Side Effect Profile of Interferon Beta-1b in MS:Results of an Open Label Trial
Neurol 46:552-554, Neilley,L.K.,et al, 1996
Age and Guillain-Barre Syndrome Severity
Muscle & Nerve 19:375-377996., Sheth,R.D.,et al, 1996
Neurologic Consequences of HTLV-II Infection in Injection-Drug Users
Neurol 46:1556-1560, Dooneief,G.,et al, 1996
Sustained Myoglobinuria:The Presenting Manifestation of Dermatomyositis
Neurol 47:119-123, Rose,M.R.,et al, 1996
Multiple Mitochondrial DNA Deletions in Sporadic Inclusion Body Myositis:A Study of 56 Patients
Ann Neurol 39:789-795, Santorelli,F.M.,et al, 1996
Is Chronic Respiratory Failure in Neuromuscular Diseases Worth Treating
JNNP 61:1-3, Shneerson,J.M., 1996
Human T-Cell Lymphotropic Virus Type 1-Associated Myelopathy, Sjogren Syndrome, and Lymphocytic Pneumonitis
Arch Neurol 53:940-942, Kompoliti,A.,et al, 1996
Interferon-Alpha is Effective in HTLV-I-Associated Myelopathy:A Multicenter, Randomized, Double-Blind, Controlled Trial
Neurol 46:1016-1021, Izumo,S.,et al, 1996
The Management of Brainstem Gliomas in Patients with Neurofibromatosis 1
Neurol 46:1652-1660, Pollack,I.F.,et al, 1996
Intravenous Immunoglobulin Treatment of Neurological Disease
JNNP 60:359-361, Otten,A.,et al, 1996
A Woman with a Relapsing Psychosis Who Got Better with Prednisone
Lancet 347:1288, Cohen,L.,et al, 1996
Cost-Effectiveness Analysis:What Is It and How Will It Influence Neurology
Ann Neurol 39:818-823, Holloway,R.G., 1996
The"Gulf War Syndrome"-Is There Evidence of Dysfunction in the Nervous System
JNNP 60:449-451, Jamal,G.A.,et al, 1996
Pure Motor Hand Weakness
Semin Neurol 16:75-81, Lewis,R.A., 1996
Peripheral Neuropathy Secondary to Docetaxel (Taxotere)
Neurol 46:108-111, 21996., New,P.Z.,et al, 1996
Development of Cardiomyopathy in Female Carriers of Duchenne and Becker Muscular Dystrophies
JAMA 275:1335-1338, Politano,L.,et al, 1996
A New Variant of Creutzfeldt-Jakob Disease in the UK
Lancet 347:921-925, 915, 916, 91796., Will,R.G.,et al, 1996
Creutzfeldt-Jakob Disease in a Young Woman
Lancet 347:945-948, Tabrizi,S.J.,et al, 1996
Cytomegalovirus Infection and Guillain-Barre Syndrome:The Clinical, Electrophysiologic, and Prognostic Features
Neurol 47:668-673, Visser,L.H.,et al, 1996
Prospective Evaluation of MRI Lumbosacral Nerve Root Enhancement in Acute Guillain-Barre Syndrome
Neurol 47:813-817, Gorson,K.C.,et al, 1996